carbapenems has been researched along with amoxicillin-potassium clavulanate combination in 8 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (amoxicillin-potassium clavulanate combination) | Trials (amoxicillin-potassium clavulanate combination) | Recent Studies (post-2010) (amoxicillin-potassium clavulanate combination) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 2,827 | 612 | 1,011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Allen, S; Barry, A; Fuchs, P; McLaughlin, J; Pfaller, M; Sewell, D | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Dance, D | 1 |
Arora, R; Chakotiya, AS; Chawla, R; Goel, R; Narula, A; Sharma, RK; Tanwar, A; Thakur, P | 1 |
Ang, B; Cai, Y; Chew, KL; Chow, A; Cuvin, CA; Fisher, DA; Goossens, H; Hsu, LY; Kurup, A; Kwa, AL; Lee, W; Liew, YX; Lim, CH; Ling, ML; Low, CY; Lye, DC; Marimuthu, K; Nguyen, VH; Oh, HM; Ooi, ST; Pada, SK; Tambyah, PA; Tan, JWC; Tan, TY; Tee, NW; Venkatachalam, I; Wang, Y; Wong, SY | 1 |
Cayo da Silva, R; Esimone, CO; Gales, AC; Iroha, IR; Moses, IB; Ribeiro, ÁCDS; Rubin, JE; Santos, FF; Sniatynsky, MK | 1 |
Chacko, S; Maheshwari, TK; Murdeshwar, S; Sheikh, RY | 1 |
Mewa Kinoo, S; Ramjathan, P; Singh, B; Singh, R; Swe Swe-Han, K | 1 |
1 review(s) available for carbapenems and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Treatment and prophylaxis of melioidosis.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim | 2014 |
7 other study(ies) available for carbapenems and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; United States | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Camellia sinensis Ameliorates the Efficacy of Last Line Antibiotics Against Carbapenem Resistant Escherichia coli.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactams; Camellia sinensis; Carbapenems; Colistin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Flavonoids; Free Radical Scavengers; Meropenem; Microbial Sensitivity Tests; Minocycline; Phytochemicals; Plant Extracts; Plant Leaves; Thienamycins; Tigecycline | 2016 |
Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey.
Topics: Age Factors; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cross Infection; Female; General Surgery; Health Surveys; Hospitals; Humans; Inpatients; Male; Middle Aged; Practice Patterns, Physicians'; Prevalence; Pseudomonas aeruginosa; Sex Factors; Singapore; Staphylococcus aureus | 2017 |
Antibiotypes and high frequency of toxin genes in methicillin-resistant Staphylococcus pseudintermedius from nares of dogs and dog guardians in Nigeria.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Dog Diseases; Dogs; Fluoroquinolones; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nigeria; Staphylococcal Infections; Staphylococcus | 2022 |
Microbiological Spectrum and Antibiogram of Urinary Tract Infection in a Tertiary Care Center from the Kingdom of Bahrain.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bahrain; beta-Lactamases; Carbapenems; Ciprofloxacin; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Levofloxacin; Male; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Microbiological analysis and predictors of gallbladder infection with antimicrobial susceptibility patterns in an HIV setting.
Topics: Aged; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Gallbladder Diseases; HIV; HIV Infections; Humans; Retrospective Studies; South Africa | 2023 |